Industrial Synthesis Route and Purity Standards for Methyl 2,4-Difluorobenzoate

• High-Yield Esterification: Optimized conversion from 2,4-difluorobenzoic acid ensures consistent assay standards above 98.0%.
• Strict Quality Control: Industrial purity is maintained through rigorous GC analysis and distillation protocols.
• Reliable Bulk Supply: Partnering with a verified global manufacturer guarantees stable bulk price and timely delivery.

Methyl 2,4-Difluorobenzoate (CAS: 106614-28-2) is a critical fluorinated intermediate utilized extensively in the design and synthesis of pharmaceutical compounds, including integrin αvβ3 antagonists. As demand for fluorinated building blocks increases within the medicinal chemistry sector, the focus on robust synthesis route optimization and consistent industrial purity has become paramount for procurement managers. NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier global manufacturer dedicated to supplying high-quality organic intermediates that meet stringent international specifications.

This technical overview details the production methodologies, quality assurance parameters, and commercial considerations necessary for securing reliable supply chains for this essential reagent.

Optimizing Esterification for ≥98.0% Assay Standards

The production of 2,4-Difluoro-benzoic acid methyl ester typically proceeds via the esterification of 2,4-difluorobenzoic acid. In an industrial setting, the choice of catalyst and reaction conditions significantly impacts the final yield and impurity profile. A common and effective manufacturing process involves the reaction of the parent acid with methanol in the presence of a chlorinating agent such as thionyl chloride or an acid catalyst.

Technical data indicates that maintaining the reaction mixture at controlled temperatures, often starting near 0 °C and gradually warming to room temperature, minimizes side reactions. Upon completion, the crude product is typically quenched into a saturated aqueous bicarbonate solution. Subsequent extraction with organic solvents like ether or ethyl acetate, followed by drying over anhydrous magnesium sulfate, prepares the material for purification. While laboratory scales may utilize silica gel column chromatography, industrial scale-up relies on fractional distillation to achieve the necessary throughput and cost efficiency. This approach consistently delivers yields approaching 97%, ensuring economic viability for large-scale operations.

Impurity Profiles in Fluorinated Benzoate Production

Achieving high industrial purity requires more than just high conversion rates; it demands rigorous control over specific impurities. Fluorinated aromatics can present challenges regarding residual halides, unreacted acids, and isomeric byproducts. Gas Chromatography (GC) is the standard analytical method for verifying purity levels, with top-tier suppliers targeting assays greater than 98.0%.

Key physical constants serve as initial indicators of quality. For instance, the boiling point should remain within the range of 128-129 °C, and the density should approximate 1.384 g/mL at 25 °C. Deviations in these values often signal the presence of solvent residues or incomplete reaction products. Furthermore, the appearance of the liquid should be colorless to light yellow. Darkening or significant orange hues may indicate oxidation or thermal degradation during the distillation phase. Comprehensive Quality Control protocols ensure that every batch meets these physical and chemical benchmarks before release.

Scaling Lab Synthesis to Industrial Purity Levels

Transitioning from gram-scale laboratory synthesis to kilogram or ton-scale production introduces variables that can affect the final bulk price and availability. Heat transfer efficiency, mixing dynamics, and separation capabilities differ vastly between benchtop and plant environments. A competent supplier must demonstrate the ability to scale the synthesis route without compromising the impurity profile.

For procurement specialists evaluating potential vendors, requesting a Certificate of Analysis (COA) is essential. The COA should detail not only the main assay but also specify limits for water content, heavy metals, and related substances. When sourcing high-purity Methyl 2,4-Difluorobenzoate, buyers should verify that the manufacturer employs validated analytical methods consistent with pharmacopoeial standards where applicable. This ensures the material is suitable for downstream pharmaceutical applications.

Technical Specifications and Safety Data

Understanding the physicochemical properties is vital for safe handling and storage. The following table outlines the critical specifications for this compound based on standard industrial data.

Property	Specification
CAS Number	106614-28-2
Molecular Formula	C8H6F2O2
Molecular Weight	172.13 g/mol
Appearance	Colorless to Light yellow liquid
Boiling Point	128-129 °C
Density	1.384 g/mL at 25 °C
Flash Point	180 °F
Storage Conditions	Sealed in dry, Room Temperature
GHS Symbols	GHS05, GHS07
Hazard Statements	H302, H315, H318, H335

Safety handling requires adherence to standard protocols for irritants and acute toxins. Personnel should utilize appropriate Personal Protective Equipment (PPE), including eyeshields, faceshields, gloves, and type ABEK respirator filters. The compound is classified under Hazard Classifications including Acute Tox. 4 Oral and Eye Dam. 1. Proper storage in combustible liquids storage classes ensures facility compliance.

Commercial Procurement and Supply Chain Stability

In the current market landscape, stability of supply is as critical as chemical quality. Fluctuations in raw material costs for fluorinated precursors can impact the bulk price of the final ester. Established manufacturers mitigate these risks through long-term contracts with raw material suppliers and efficient inventory management.

NINGBO INNO PHARMCHEM CO.,LTD. offers a streamlined procurement process for international buyers, ensuring that documentation such as MSDS and COA is readily available. By focusing on a robust manufacturing process and maintaining high stock levels of key intermediates, we reduce lead times and support continuous production schedules for our clients. Whether for research and development or large-scale commercial synthesis, securing a partnership with a reliable source ensures that project timelines are met without compromise on quality.

In conclusion, the successful integration of Methyl 2,4-Difluorobenzoate into pharmaceutical workflows depends on selecting a supplier with proven technical expertise and capacity. By prioritizing verified industrial purity and transparent quality data, manufacturers can ensure the efficacy and safety of their final drug products.